HistoSonics
Inventor of histotripsy, non-invasive tumour destruction with focused ultrasound bubbles; acquired for $2.25B in 2025.
Edison system (liver tumours FDA 2023); kidney and pancreas trials; #HOPE4KIDNEY.
Pages like this
not linked directly; found by shared links- InstitutionUVA Comprehensive Cancer Center
Shares Histotripsy as an immune primer, Focused ultrasound & histotripsy.
- TechnologyIrreversible electroporation (NanoKnife)
Shares Mechanically pulverise one tumour with ultrasound to wake the immune system, Device-agnostic public trials of ablation technologies against surgery.
- CompanyInsightec
Shares Device-agnostic public trials of ablation technologies against surgery, Focused ultrasound & histotripsy.
- IdeaMandatory staged registries for new surgical techniques before wide adoption
Shares Device-agnostic public trials of ablation technologies against surgery, Focused ultrasound & histotripsy.
- TechnologyThermal ablation (RFA, microwave, cryo)
Shares Histotripsy as an immune primer, Mechanically pulverise one tumour with ultrasound to wake the immune system, Device-agnostic public trials of ablation technologies against surgery.
- TermAbscopal effect
Shares Histotripsy as an immune primer, Mechanically pulverise one tumour with ultrasound to wake the immune system.
- TermImmunogenic cell death
Shares Histotripsy as an immune primer, Mechanically pulverise one tumour with ultrasound to wake the immune system.